QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zempleni, J. Articles by Mock, D. M. Search for Related Content PubMed PubMed Citation Articles by Zempleni, J. Articles by Mock, D. M.

---

Supplement

Advanced Analysis of Biotin Metabolites in Body Fluids Allows a More Accurate Measurement of Biotin Bioavailability and Metabolism in Humans

Department of Pediatrics, University of Arkansas for Medical Sciences/Arkansas Children's Hospital Research Institute, Little Rock, AR 72202

In previous studies, the bioavailability of biotin in humans was estimated from the recovery of biotin in urine; urinary biotin was measured by microbial growth assays or assays of avidin-binding activity. These assays underestimate concentrations of biotin metabolites, which originate from ß-oxidation, sulfur oxidation or a combination. We have developed an HPLC/avidin-binding assay that is specific for biotin and its metabolites. With the use of the HPLC/avidin-binding assay, TLC and derivatization with p-dimethylaminocinnamaldehyde, we have identified and quantitated biotin and metabolites in urine from six healthy adults. Of that total, biotin accounted for 32 ± 12%, bisnorbiotin for 52 ± 15%, bisnorbiotin methyl ketone for 7.9 ± 5.8%, biotin-d,l-sulfoxide for 4.0 ± 3.2% and biotin sulfone for 3.6 ± 1.9%. After intravenous administration of 18.4 µmol of biotin, the urinary excretion of biotin metabolites increased 21–130 times above baseline values. Because the biliary excretion of biotin is quantitatively minor (1.9 ± 0.2% of an intravenous [¹⁴C]biotin dose in rats), intravenously administered biotin is not exposed to intestinal microorganisms. Thus we conclude that biotin metabolites in human urine originate from biotin catabolism in human tissues rather than biotin catabolism by intestinal microorganisms. With the use of the HPLC/avidin-binding assay, we estimated the bioavailability of biotin in adults from the urinary excretion of biotin and metabolites after ingestion of 2.1, 8.2 and 81.9 µmol of biotin. These data provide evidence that biotin is nearly completely absorbed.

KEY WORDS: • analysis • bioavailability • biotin • biotin metabolites • humans

This article has been cited by other articles:

				T. E. Peterson, L. R. McDowell, R. J. McMahon, N. S. Wilkinson, O. Rosendo, W. M. Seymour, P. R. Henry, F. G. Martin, and J. K. Shearer Balance and serum concentration of biotin in sheep fed alfalfa meal-based diets with increasing level of concentrate J Anim Sci, April 1, 2004; 82(4): 1165 - 1169. [Abstract] [Full Text] [PDF]

				S. C. Rathman, S. Eisenschenk, and R. J. McMahon The Abundance and Function of Biotin-Dependent Enzymes Are Reduced in Rats Chronically Administered Carbamazepine J. Nutr., November 1, 2002; 132(11): 3405 - 3410. [Abstract] [Full Text] [PDF]